Literature DB >> 14563480

Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds.

Monica Pallis1, Tracey D Bradshaw, Andrew D Westwell, Martin Grundy, Malcolm F G Stevens, Nigel Russell.   

Abstract

The dithiol-reducing thioredoxin/thioredoxin reductase system normally maintains the reduced state of key enzymes responsible for the cell's anti-oxidant defences. We therefore addressed the question of whether AW 464--a novel thioredoxin inhibitor--as well as broad spectrum dithiol ligands diamide and phenylarsine oxide are able to induce and execute a regular apoptotic sequence of events without overwhelming the cell's ability to detoxify reactive oxygen species. All three agents were found to target the thioredoxin system in a cell-free assay. In HL-60 leukaemia cells, they were also found to induce Bak activation, cytochrome c release from mitochondria, decreasing Delta Psi m, chromatin condensation, phosphatidyl serine exposure and Tdt-sensitive DNA nicks. At the onset of apoptosis there was no evidence of increases in oxygen free radicals or peroxide in cells treated with AW 464 or diamide. Phenylarsine oxide induced both free radicals and hydrogen peroxide, but this did not appear to interfere with apoptosis. We conclude that pharmacological targeting of thioredoxin can induce a well-orchestrated apoptotic programme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563480     DOI: 10.1016/s0006-2952(03)00471-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.

Authors:  Natarajan Raghunand; Bhumasamudram Jagadish; Theodore P Trouard; Jean-Philippe Galons; Robert J Gillies; Eugene A Mash
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

2.  A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Authors:  A Mukherjee; K Huber; H Evans; N Lakhani; S Martin
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

3.  Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide.

Authors:  Christopher Horst Lillig; Maria Elisabet Lönn; Mari Enoksson; Aristi Potamitou Fernandes; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

4.  Inhibition of DNA primase and induction of apoptosis by 3,3'-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells.

Authors:  Zhi-Ming Li; Zong-Chao Liu; Zhong-Zhen Guan; Xiao-Feng Zhu; Jun-Min Zhou; Bing-Fen Xie; Gong-Kan Feng; Zhen-Yu Zhu; Wen-Qi Jiang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

5.  A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.

Authors:  Zuo-Fu Peng; Lin-Xiang Lan; Fang Zhao; Jing Li; Qiang Tan; Han-Wei Yin; Hui-Hui Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2008-01       Impact factor: 3.066

6.  Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.

Authors:  Janine König; Susan Wyllie; Geoffrey Wells; Malcolm F Stevens; Paul G Wyatt; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

7.  Quinol derivatives as potential trypanocidal agents.

Authors:  Amy Capes; Stephen Patterson; Susan Wyllie; Irene Hallyburton; Iain T Collie; Andrew J McCarroll; Malcolm F G Stevens; Julie A Frearson; Paul G Wyatt; Alan H Fairlamb; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2011-12-27       Impact factor: 3.641

8.  Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.

Authors:  A Mukherjee; A D Westwell; T D Bradshaw; M F G Stevens; J Carmichael; S G Martin
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

9.  PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cells.

Authors:  M E Callister; L Pinhu; M C Catley; A D Westwell; R Newton; S K Leaver; G J Quinlan; T W Evans; M J Griffiths; A Burke-Gaffney
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

10.  Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells.

Authors:  Monica Pallis; Francis Burrows; Jeremy Ryan; Martin Grundy; Claire Seedhouse; Amina Abdul-Aziz; Joan Montero; Anthony Letai; Nigel Russell
Journal:  Oncotarget       Date:  2017-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.